Lactobacillus helveticus strain and composition for preventing or treating inflammatory disease containing same

• Main Authors: YANG BO-KI, KANG CHANG-HO, ZHANG MINGHAO, BAEK NAM-SOO
• Format: Patent
• Language: Chinese; English
• Published: 30.12.2022
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS THEREOF; CULTURE MEDIA; ENZYMOLOGY; FODDER; FOODS OR FOODSTUFFS; FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BYSUBCLASSES A23B - A23J; HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; METALLURGY; MICROBIOLOGY; MICROORGANISMS OR ENZYMES; MUTATION OR GENETIC ENGINEERING; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL; PROCESSES USING MICROORGANISMS; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS; SPIRITS; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OFNUTRITIVE QUALITIES, PHYSICAL TREATMENT; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES; VINEGAR; WINE

Provided are a Lactobacillus helveticus strain and a composition for preventing or treating inflammatory diseases containing the same. The Lactobacillus helveticus strain (preservation number KCTC 14110BP) according to the present invention alleviates the symptoms of inflammatory bowel disease, such as weight loss and gut length shortening, and does not have side effects found in existing drug therapy. Therefore, the Lactobacillus helveticus strain can be effectively used for treating and preventing inflammatory diseases, in particular inflammatory bowel diseases. 提供一种瑞士乳杆菌菌株和含有该菌株的用于预防或治疗炎性疾病的组合物。根据本发明的瑞士乳杆菌菌株(保藏号KCTC 14110BP)缓解炎性肠病的例如体重减轻和肠道长度缩短的症状，并且没有现有药物治疗中所见的副作用。因此，瑞士乳杆菌菌株可有效用于治疗和预防炎性疾病，特别是炎性肠病。